Sakan Binte Imran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sakan Binte Imran has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Noor Un Nisa Irshad
Jinnah Sindh Medical University, Karachi, Pakistan
20 shared publications - Muhammad Talha
King Edward Medical University, Lahore, Pakistan
11 shared publications - Ehtisham Haider
Department of Medicine, Punjab Medical College, Faisalabad, Pakistan
7 shared publications - Hamza Sajid
Allama Iqbal Medical College Lahore Pakistan
7 shared publications - Laiba Shamim
Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan
7 shared publications - Mir Raza Ali
Jinnah Postgraduate Medical Centre, Karachi, Pakistan
5 shared publications
Latest Publications
- Open Access
- 9 September 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (10) , 6924-6925
Zidesamtinib in ROS1-positive NSCLC with brain metastases: clinical evidence and therapeutic implications
- 9 September 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (10) , 6924-6925
Open AccessZidesamtinib in ROS1-positive NSCLC with brain metastases: clinical evidence and therapeutic implications
- Open Access
- 15 May 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (7) , 4738-4739
Brensocatib in non-cystic fibrosis bronchiectasis: targeting neutrophil-driven inflammation through DPP-1 inhibition
Was not provided for this article.
- 15 May 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (7) , 4738-4739
Open AccessBrensocatib in non-cystic fibrosis bronchiectasis: targeting neutrophil-driven inflammation through DPP-1 inhibition
Was not provided for this article.
- Open Access
- 13 May 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (6) , 3054-3055
Machine learning for Charcot-Marie-Tooth disease: toward predictive, personalized neuropathy care
- 13 May 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (6) , 3054-3055
Open AccessMachine learning for Charcot-Marie-Tooth disease: toward predictive, personalized neuropathy care
- Open Access
- 30 March 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (4) , 2475-2476
CRISPR–Cas12a for Birt–Hogg–Dubé syndrome: a promising diagnostic tool for deep intronic variant detection
- 30 March 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (4) , 2475-2476
Open AccessCRISPR–Cas12a for Birt–Hogg–Dubé syndrome: a promising diagnostic tool for deep intronic variant detection
- Open Access
- 18 February 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (3) , 2460-2461
YCT-529: a promising oral non-hormonal male contraceptive and its implications for family planning
- 18 February 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (3) , 2460-2461
Open AccessYCT-529: a promising oral non-hormonal male contraceptive and its implications for family planning
- Open Access
- 20 January 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (2) , 2208-2209
Bridging the gap: the need for pediatric-specific AI models for tuberculosis detection on chest radiographs
- 20 January 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (2) , 2208-2209
Open AccessBridging the gap: the need for pediatric-specific AI models for tuberculosis detection on chest radiographs
- Open Access
- 6 January 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (2) , 2158-2159
Gut–brain axis in neurology: microbiome as a modifiable risk factor for multiple sclerosis
- 6 January 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (2) , 2158-2159
Open AccessGut–brain axis in neurology: microbiome as a modifiable risk factor for multiple sclerosis
- Open Access
- 6 January 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (2) , 2178-2179
Revuforj (revumenib): a novel menin inhibitor for relapsed or refractory acute leukemia
- 6 January 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (2) , 2178-2179
Open AccessRevuforj (revumenib): a novel menin inhibitor for relapsed or refractory acute leukemia
- Open Access
- 6 January 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (2) , 2184-2185
FDA approval of SetPoint System: the first neuroimmune modulation therapy for rheumatoid arthritis
- 6 January 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (2) , 2184-2185
Open AccessFDA approval of SetPoint System: the first neuroimmune modulation therapy for rheumatoid arthritis
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Diabetes Research
- Vol. 2026 (1) , 5163895
Association Between Exercise and Brain‐Derived Neurotrophic Factor (BDNF) Levels in Diabetes Mellitus: A Systematic Review and Meta‐Analysis
Background: Diabetes mellitus (DM) is a metabolic disorder characterized by a consistently elevated blood sugar level. DM poses a major risk factor for many neurodegenerative diseases, causing a decline in cognitive function. BDNF (brain‐derived neurotrophic factor) is a neurotrophin in the central and peripheral nervous systems that plays a crucial role in the development of brain circuits. Hence, disturbance in levels of BDNF is linked to the occurrence of neurodegenerative diseases and cognitive decline in diabetic patients. Physical exercise has emerged as a nonpharmacological intervention in elevating BDNF levels. Our systematic review and meta‐analysis evaluate the relationship between a globally affecting metabolic disorder, diabetes, with decreased BDNF levels, and explore exercise as a promising potential intervention. Methods: After screening 37 articles, 4 studies have been included in the systematic review and meta‐analysis, out of which 3 of them are randomized controlled trials (RCTs), and 1 is a crossover trial. The search was conducted on PubMed (MEDLINE), ScienceDirect, Embase, Scopus, and Cochrane Central databases from inception to June 2025. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta‐Analyses) guidelines were followed to conduct a systematic review. Cochrane risk‐of‐bias tool was used to assess the quality of the studies. Data were pooled using a random effect model. The protocol for this systematic review was registered in PROSPERO. Results: A total of 37 articles were screened, 3 RCTs and 1 crossover trial with 131 participants were included in the meta‐analysis. Serum BDNF levels were higher in the exercise group compared with controls (MD = 73.50; p = 0.05). A small reduction in body fat percentage in the exercise group compared with the control was found (MD = −1.24 % ; p = 0.17), which was not statistically significant. Body weight and fasting blood glucose (FBG) showed no statistically significant differences between the exercise and control groups (MD = 0.97; p = 0.65), (MD = −27.20; p = 0.31). Moderate to high heterogeneity was noticed across the data analyzed. Conclusion: This meta‐analysis overall concludes that regular exercise positively affects serum BDNF levels in diabetics. However, the small number of trials and small sample sizes has limited the conclusions. Further large‐scale RCTs are required to determine the long‐term neurological effects of exercise in diabetics.
- 1 January 2026
- Published by Wiley in Journal of Diabetes Research
- Vol. 2026 (1) , 5163895
Open AccessAssociation Between Exercise and Brain‐Derived Neurotrophic Factor (BDNF) Levels in Diabetes Mellitus: A Systematic Review and Meta‐Analysis
Background: Diabetes mellitus (DM) is a metabolic disorder characterized by a consistently elevated blood sugar level. DM poses a major risk factor for many neurodegenerative diseases, causing a decline in cognitive function. BDNF (brain‐derived neurotrophic factor) is a neurotrophin in the central and peripheral nervous systems that plays a crucial role in the development of brain circuits. Hence, disturbance in levels of BDNF is linked to the occurrence of neurodegenerative diseases and cognitive decline in diabetic patients. Physical exercise has emerged as a nonpharmacological intervention in elevating BDNF levels. Our systematic review and meta‐analysis evaluate the relationship between a globally affecting metabolic disorder, diabetes, with decreased BDNF levels, and explore exercise as a promising potential intervention. Methods: After screening 37 articles, 4 studies have been included in the systematic review and meta‐analysis, out of which 3 of them are randomized controlled trials (RCTs), and 1 is a crossover trial. The search was conducted on PubMed (MEDLINE), ScienceDirect, Embase, Scopus, and Cochrane Central databases from inception to June 2025. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta‐Analyses) guidelines were followed to conduct a systematic review. Cochrane risk‐of‐bias tool was used to assess the quality of the studies. Data were pooled using a random effect model. The protocol for this systematic review was registered in PROSPERO. Results: A total of 37 articles were screened, 3 RCTs and 1 crossover trial with 131 participants were included in the meta‐analysis. Serum BDNF levels were higher in the exercise group compared with controls (MD = 73.50; p = 0.05). A small reduction in body fat percentage in the exercise group compared with the control was found (MD = −1.24 % ; p = 0.17), which was not statistically significant. Body weight and fasting blood glucose (FBG) showed no statistically significant differences between the exercise and control groups (MD = 0.97; p = 0.65), (MD = −27.20; p = 0.31). Moderate to high heterogeneity was noticed across the data analyzed. Conclusion: This meta‐analysis overall concludes that regular exercise positively affects serum BDNF levels in diabetics. However, the small number of trials and small sample sizes has limited the conclusions. Further large‐scale RCTs are required to determine the long‐term neurological effects of exercise in diabetics.